Table:
Mean intra-participant difference in FeNO (ppb) (95% CI) [p-value] *	Standard deviation (SD) of the intra-participant difference in FeNO (ppb)	95% limits of agreement (ppb)
All participants	1.37	4.58	-7.61 to 10.34
(n = 494)	(0.96, 1.77) [<0.001]
Males	1.43	4.97	-8.30 to 11.17
(n = 251)	(0.82, 2.05) [<0.001]
Females	1.30	4.15	-6.83 to 9.43
(n = 243)	(0.77, 1.82) [<0.001]
Participants with a low FEV1	2.01	5.21	-8.20 to 12.22
(n = 162)	(1.20, 2.81) [<0.001]
Participants with a high FEV1	1.07	3.75	-6.28 to 8.42
(n = 162)	(0.49, 1.65) [<0.001]
Participants with asthma	2.37	7.01	-11.38 to 16.12
(n = 71)	(0.71, 4.03) [0.006]
All others participants	1.19	4.09	-6.82 to 9.20
(n = 401)	(0.79, 1.59) [<0.001]

Continue parse the photo with markdown style: |  | Mean intra-participant difference in FeNO (ppb) (95% CI) [p-value] * | Standard deviation (SD) of the intra-participant difference in FeNO (ppb) | 95% limits of agreement (ppb) | 
 | --- | --- | --- |

--- | 
 | All participants | 1.37 | 4.58 | -7.61 to 10.34 | 
 | (n = 494) | (0.96, 1.77) [<0.001] |  |  | 
 | Males | 1.43 | 4.97 | -8.30 to 11.17 | 
 | (n = 251) | (0.82, 2.05) [<0.001] |  |  | 
 | Females | 1.30 | 4.15 | -6.83 to 9.43 | 
 | (n = 243) | (0.77, 1.82) [<0.001] |  |  | 
 | Participants with a low FEV1 | 2.01 | 5.21 | -8.20 to 12.22 | 
 | (n = 162) | (1.20, 2.81) [<0.001] |  |  | 
 | Participants with a high FEV1 | 1.07 | 3.75 | -6.28 to 8.42 | 
 | (n = 162) | (0.49, 1.65) [<0.001] |  |  | 
 | Participants with asthma | 2.37 | 7.01 | -11.38 to 16.12 | 
 | (n = 71) | (0.71, 4.03) [0.006] |  |  | 
 | All others participants | 1.19 | 4.09 | -6.82 to 9.20 | 
 | (n = 401) | (0.79, 1.59) [<0.001] |  |  |